Lupkynis (voclosporin) - Aurinia Pharma
mycophenolate mofetil - Generic mfg.
Real-World Use of Voclosporin in Lupus Nephritis (KIDNEY WEEK 2025) - Oct 18, 2025 - Abstract #SA-PO0859; Pres time: Nov 8, 2025; 10:00 AM - 12:00 PM; Location: Exhibit Hall, Convention Center; "Used in combination with mycophenolate mofetil it allowed for the rapid taper of steroids and significantly increased the number of patients achieving complete renal response (CRR) when compared to mycophenolate mofetil and steroids alone. The other person discontinued voclosporin for a short period time due to a respiratory tract infection and has since re-instated voclosporin. In our experience, those who have good secretory renal function but are heavily proteinuric benefit from voclosporin add-on therapy in LN." 
Clinical • Real-world • Real-world evidence • Glomerulonephritis • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Respiratory Diseases
https://www.asn-online.org/education/kidneyweek/2025/program-abstract.aspx?controlId=4351010
 
Khoanh Iien Nhuien; Luxme Nadarajah; Angela Pakozdi; Dev Pyne; Andrea Cove-Smith; Ravindra Rajakariar
 
Oct 18, 2025
 
Prev Next